Grovit Chewable Tablet

• Vitamin A - 1600 Iu
• Vitamin B1 - 1Mg
• Vitamin B2 - 1Mg
• Vitamin B12 - 1 Mcg
• Vitamin E - 10Mg
• Vitamin C - 20Mg
• Folic Acid - 0.1Mg
• Vitamin D3 - 100 Iu
• Calcium Pantothenate - 2.5Mg
• Sodium Ascorbate -45Mg
• Grovit Chewable Tablet works by facilitating retina formation required for low light and color vision; metabolizing carbohydrate thus maintains normal growth; maintaining many tissues of the body to prevent vitamin B2 deficiency; treating vitamin B12 deficiency; slowing down the processes that damage cells; blocking the damage caused by free radicals thus heals wounds; acting on megaloblastic bone marrow to produce a normoblastic marrow; increasing absorption of calcium and phosphorus required for strong bones; protecting cells against peroxidative damage by increasing the level of glutathione; treat low levels of vitamin C in people who do not get enough vitamin from their diets;

Dosage and Administration:

• Vitamin a deficiency
• Eye problems
• Skin diseases
• Thiamine deficiency
• Neurological disorders
• Heart problem
• Eye disorders
• Migraine headache
• Hyperhomocysteinemia
• Vitamin b12 deficiency
• Pernicious anemia
• Heart attack
• Chest pain
• Leg pain due to blocked arteries
• High blood pressure
• Scurvy
• Cell damage
• Wound healing
• Tissue repair
• Red blood cell production
• Treatment of megaloblastic anemias due to a deficiency of folic acid
• Treatment of anemias of nutritional origin, pregnancy, infancy, or childhood
• Vitamin d deficiency
• Streptomycin neurotoxicity
• Salicylate toxicity
• Gray hair
• Alopecia
• Catarrhal respiratory disorders
• Osteoarthritis
• Diabetic neuropathy
• Psychiatric states
• Congenital hypothyroidism
• Low levels of vitamin c
• Grovit Chewable Tabletmay also be used for purposes not listed here.

Pharmacodynamics

Side Effects:

Precautions

Dosage

Food(before/after)

List of Contraindications

Pregabalin+Mecobalamin and Pregnancy

Pregabalin+Mecobalamin and Lactation

Lab interference

• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
• Medications are known to interact with Scotts Emulsion (multivitamin)

• • anisindione
  • bortezomib
  • capecitabine
  • cholestyramine
  • colesevelam
  • colestipol
  • dicumarol
  • fluorouracil
  • orlistat
  • sevelamer
  • warfarin SCOTT’S EMULSION DOSAGE

• For the treatment of folate-deficient megaloblastic anaemia due to malnutrition, malabsorption syndromes (such as coeliac disease or sprue) and increased utilisation as in pregnancy. It should not be used alone in undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aetiology, unless administered with adequate amounts of hydroxocobalamin.
• For the prophylaxis of drug induced folate deficiency e.g., caused by administration of phenytoin, phenobarbital and primidone. (See section 4.5).
• For the prophylaxis against folate deficiency in chronic haemolytic states or in renal dialysis.
• For the prevention of neural tube defects for woman planning a pregnancy and known to be at risk

• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
• Long-term folate therapy is contraindicated in any patient with untreated cobalamin deficiency. This can be untreated pernicious anaemia or other cause of cobalamin deficiency, including lifelong vegetarians. In elderly people, a cobalamin absorption test should be done before long-term folate therapy. Folate given to such patients for 3 months or longer has precipitated cobalamin neuropathy. No harm results from short courses of folate
• Folic acid should never be given alone in the treatment of Addisonian pernicious anaemia and other vitamin B₁₂deficiency states because it may precipitate the onset of subacute combined degeneration of the spinal cord
• Folic acid should not be used in malignant disease unless megaloblastic anaemia owing to folate deficiency is an important complication.

• Patients with vitamin B₁₂deficiency should not be treated with folic acid unless administered with adequate amounts of hydroxocobalamin, as it can mask the condition but the subacute irreversible damage to the nervous system will continue. The deficiency can be due to undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aethiology or other cause of cobalamin deficiency, including lifelong vegetarians.
• Caution should be exercised when administering folic acid to patients who may have folate dependent tumours.
• This product is not intended for healthy pregnant women where lower doses are recommended, but for pregnant women with folic acid deficiency or women at risk for the reoccurrence of neural tube defects.
• This product contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose – galactose malabsorption should not take this medicine